Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells

Details for Australian Patent Application No. 2004229311 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Kretz-Rommel, Anke; Bowdish, Katherine S.; Dakappagari, Naveen

Agent Shelston IP

Pub. Number AU-B-2004229311

PCT Pub. Number WO2004/091543

Priority 60/451,816 04.03.03 US; 60/529,500 15.12.03 US; 60/548,385 28.02.04 US

Filing date 4 March 2004

Wipo publication date 28 October 2004

Acceptance publication date 9 July 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 39/40 (2006.01) Medicinal preparations containing antigens or antibodies - bacterial

A61K 39/42 (2006.01) Medicinal preparations containing antigens or antibodies - viral

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/091543 Priority application(s): WO2004/091543

9 July 2009 Application Accepted

  Published as AU-B-2004229311

5 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229313-Amylases, nucleic acids encoding them and methods for making and using them

2004229303-Enhancing clarity and/or stability properties of protein-containing liquids and gels